| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 37.1 | 47.6 |
| Gross profit | 28.0 | 37.8 |
| Profit before tax | -0.2 | 2.2 |
| Net income | -0.2 | 2.2 |
| EPS (diluted, $ a share) | $-0.02 | $0.17 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -22.0% |
|---|---|
| Gross margin | 75.4% |
| Operating margin | -0.4% |
10-Q filed with the SEC, NASDAQ: LFVN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Lifevantage Corp: key numbers
- Share price
- $4.77Close, Nov 16
- Market cap
- $59.8M
- Shares outstanding
- 12.53MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Lifevantage Corp
All →Lifevantage Director Michael A. Beindorff Sells $48.9K of Stock
Michael A. Beindorff, Director, sold 10,000 shares of Lifevantage Corp at $4.89 a share, worth $48.9K in total on Nov 12, 2026. Shares held after the trade: 31,625 (-24.0%).
- Value
- $48.9K
- Shares
- 10,000
- Price
- $4.89
- Role
- Director
- Holding change
- -24.0%
- Trade date
- Nov 12, 2026
Lifevantage Shareholder Meeting
LifeVantage Corporation held its fiscal year 2027 annual meeting of stockholders on November 5, 2026. Shareholders elected six directors to the board, approved executive compensation on an advisory basis, and ratified Deloitte & Touche, LLP as the independent accounting firm for the fiscal year ending June 30, 2027.
Lifevantage Financial Results
LifeVantage Corp reported financial results for the first quarter of fiscal 2027, with revenue declining 22% to $37.1 million due to lower active accounts and GLP-1 system sales. The company reported a net loss of $0.02 per diluted share and is implementing a new strategy to transform into a brand-driven, consumer-focused company with a more efficient operating model.
- Term
- Q1 2027
“Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it. Our focus is on transforming LifeVantage into a more brand-driven, consumer-focused company, supported by a modern digital platform and an expanding community of consumers and brand advocates.”
Terrence Moorehead, President and Chief Executive Officer
Lifevantage Other 8-K Filing
LifeVantage Corporation has changed its fiscal year end from June 30 to December 31 to align with the calendar year. The company will file a transition report on Form 10-KT for the period from July 1, 2026, to December 31, 2026.